S. Korea open to use of Ebola drug on new coronavirus after full clinical testing | Inquirer News

S. Korea open to use of Ebola drug on new coronavirus after full clinical testing

/ 04:54 PM April 30, 2020

A worker stands outside a makeshift clinic for COVID-19 tests at the National Medical Center in Seoul on Wednesday. (Yonhap) via The Korea Herald

SEOUL — South Korea will allow the use of an Ebola virus drug in treating coronavirus patients if the drug proves to be effective and safe through clinical tests, officials said Thursday.

The drug, Remdesivir, has drawn keen attention since the US National Institute of Allergy and Infectious Diseases (NIAID) said its tests showed that the drug “accelerates recovery” of COVID-19 patients.

Article continues after this advertisement

“It is true that some positive effects are being mentioned about Remdesivir,” Deputy Director Kwon Jun-wook of the Korea Centers for Disease Control and Prevention said during a daily briefing. “In case of contingencies, we will try to give it emergency use authorization and allow its domestic use.”

FEATURED STORIES

The NIAID said in a statement released on Wednesday that hospitalized patients with advanced COVID-19 and lung involvement, who received Remdesivir, recovered faster than similar patients who received placebo.

Under cooperation with the drug’s maker, Gilead Sciences, three hospitals in South Korea are also carrying out clinical tests of the drug on some 200 COVID-19 patients.

Article continues after this advertisement

Kwon said, however, that its use can be allowed only after full clinical test results are reviewed.

“At this point in time, the full clinical test results have not been tallied yet,” he said. “The disease control center and experts will keep looking into the results as they come in and make necessary preparations.” (Yonhap)

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Coronavirus, COVID-19, remdesivir, South korea

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.